Copernicus Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-9,000
| Closed | -$1.82M | – | 17 |
|
|
2021
Q2 | $1.82M | Buy |
9,000
+6,000
| +200% | +$1.21M | 28.62% | 1 |
|
|
2021
Q1 | $645K | Sell |
3,000
-85
| -3% | -$18.3K | 10.42% | 5 |
|
|
2020
Q4 | $729K | Sell |
3,085
-41,904
| -93% | -$9.9M | 11.36% | 2 |
|
|
2020
Q3 | $12.2M | Buy |
44,989
+22,684
| +102% | +$6.17M | 11.66% | 4 |
|
|
2020
Q2 | $6.48M | Sell |
22,305
-30,148
| -57% | -$8.75M | 7.1% | 5 |
|
|
2020
Q1 | $12.5M | Sell |
52,453
-5,362
| -9% | -$1.28M | 15.1% | 1 |
|
|
2019
Q4 | $12.7M | Sell |
57,815
-7,034
| -11% | -$1.54M | 16.6% | 1 |
|
|
2019
Q3 | $11M | Sell |
64,849
-6,000
| -8% | -$1.02M | 10.22% | 2 |
|
|
2019
Q2 | $13M | Buy |
70,849
+52,986
| +297% | +$9.72M | 11.56% | 1 |
|
|
2019
Q1 | $3.29M | Sell |
17,863
-15,020
| -46% | -$2.76M | 8.43% | 5 |
|
|
2018
Q4 | $5.45M | Sell |
32,883
-30,024
| -48% | -$4.98M | 10.26% | 4 |
|
|
2018
Q3 | $12.1M | Sell |
62,907
-3,533
| -5% | -$681K | 11.39% | 4 |
|
|
2018
Q2 | $11.3M | Buy |
66,440
+14,196
| +27% | +$2.41M | 8.2% | 5 |
|
|
2018
Q1 | $8.52M | Sell |
52,244
-10,047
| -16% | -$1.64M | 6.79% | 7 |
|
|
2017
Q4 | $9.34M | Buy |
+62,291
| New | +$9.34M | 6.95% | 5 |
|